Qualitas Funds has announced that Develco Pharma has been added to the Qualitas Funds Direct II portfolio. This transaction was led by one of their managers located in Germany.
Develco Pharma is a specialty pharmaceutical company that develops and produces innovative formulations for drugs with known active ingredients. After approval, the products are licensed out to internationally operating pharmaceutical companies. Develco Pharma is responsible for the entire value chain, from development and approval, to manufacture and delivery. By focusing on extended or modified releases, the company has grown into an internationally recognized and renowned provider.
cloud technology axon
ART Technologies, a Valencia-based startup specializing in hyperspectr...
Capital-Riesgo.es
Subscribe to our newsletter and stay up to date with the latest news and deals!
2013 © Capital-Riesgo.es - Site Developments SL. All Rights Reserved. Terms of Service | Privacy Policy
Articles
Directory
